Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1978 ARTÍCULOS , VIENDO DEL 706 AL 720

Significance of GABA(A) Receptor for Cognitive Function and Hippocampal Pathology

Sakimoto Y, Oo PM, Goshima M, Kanehisa I, Tsukada Y, Mitsushima D.

Int J Mol Sci. 2021 Nov 18;22(22):12456. doi: 10.3390/ijms222212456.

Willin/FRMD6: A Multi-Functional Neuronal Protein Associated with Alzheimer's Disease

Chen D, Yu W, Aitken L, Gunn-Moore F.

Cells. 2021 Nov 4;10(11):3024. doi: 10.3390/cells10113024.

Mechanosensing and the Hippo Pathway in Microglia: A Potential Link to Alzheimer's Disease Pathogenesis?

Bruno L, Karagil S, Mahmood A, Elbediwy A, Stolinski M, Mackenzie FE.

Cells. 2021 Nov 12;10(11):3144. doi: 10.3390/cells10113144.

Therapeutic Potential of Mitophagy-Inducing Microflora Metabolite, Urolithin A for Alzheimer's Disease

Jayatunga DPW, Hone E, Khaira H, Lunelli T, Singh H, Guillemin GJ, Fernando B, Garg ML, Verdile G, Martins RN.

Nutrients. 2021 Oct 23;13(11):3744. doi: 10.3390/nu13113744.

Alzheimer Disease and Sleep Disorders: Insights into the Possible Disease Connections and the Potential Therapeutic Targets (Part II)

Kamal MA, Bahbah EI.

CNS Neurol Disord Drug Targets. 2021;20(8):674-676. doi: 10.2174/187152732008210921121240.

Impact of Donepezil and Memantine on Behavioral and Psychological Symptoms of Alzheimer Disease: Six-month Open-label Study

Bago Rožanković P, Rožanković M, Badžak J, Stojić M, Šušak Sporiš I.

Cogn Behav Neurol. 2021 Dec 2;34(4):288-294. doi: 10.1097/WNN.0000000000000285.

Cholinesterase inhibitors and memantine for the treatment of Alzheimer and non-Alzheimer dementias

Balázs N, Bereczki D, Kovács T.

Ideggyogy Sz. 2021 Nov 30;74(11-12):379-387. doi: 10.18071/isz.74.0379.

β-Amyloid is an Immunopeptide and Alzheimer's is an Autoimmune Disease

Weaver DF.

Curr Alzheimer Res. 2021;18(11):849-857. doi: 10.2174/1567205018666211202141650.

Insights into the changes in the proteome of Alzheimer disease elucidated by a meta-analysis

Haytural H, Benfeitas R, Schedin-Weiss S, Bereczki E, Rezeli M, Unwin RD, Wang X, Dammer EB, Johnson ECB, Seyfried NT, Winblad B, Tijms BM, Visser PJ, Frykman S, Tjernberg LO.

Sci Data. 2021 Dec 3;8(1):312. doi: 10.1038/s41597-021-01090-8.

Genetically regulated expression in late-onset Alzheimer's disease implicates risk genes within known and novel loci

Chen HH, Petty LE, Sha J, Zhao Y, Kuzma A, Valladares O; Alzheimer’s Disease Genetics Consortium, International Genomics of Alzheimer’s Project; Bush W, Naj AC, Gamazon ER, Below JE.

Transl Psychiatry. 2021 Dec 6;11(1):618. doi: 10.1038/s41398-021-01677-0.

Gram-negative bacteria and their lipopolysaccharides in Alzheimer's disease: pathologic roles and therapeutic implications

Kim HS, Kim S, Shin SJ, Park YH, Nam Y, Kim CW, Lee KW, Kim SM, Jung ID, Yang HD, Park YM, Moon M.

Transl Neurodegener. 2021 Dec 7;10(1):49. doi: 10.1186/s40035-021-00273-y.

Multi-Target Directed Ligands (MTDLs): Promising Coumarin Hybrids for Alzheimer's Disease

Bhatia R, Chakrabarti SS, Kaur U, Parashar G, Banerjee A, Rawal RK.

Curr Alzheimer Res. 2021;18(10):802-830. doi: 10.2174/1567205018666211208140551.

The Alzheimer's Disease Amyloid Precursor Protein and its Neuritogenic Actions

Luu L, Ciccotosto GD, Cappai R.

Curr Alzheimer Res. 2021;18(10):772-786. doi: 10.2174/1567205018666211208141017.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias